قااون
                                                                
                            COMPLIANCE FOR BIOPHARMACEUTICAL 
                            Within the EMA, the Committee for Medicinal Products for Human Use (CHMP) performs the actual assessment of the application and issues a scientific opinion.
                            Learn more
                         
                                            
                            Implementation of the Biosimilar Pathway: Economic and 
                            by H Grabowski 2011 Cited by 64 The European Union has had a well-defined regulatory pathway for biosimilars in place for several years which provides one model that could
                            Learn more
                         
                                            
                            Patients and Consultants Views and Perceptions on 
                            by DC Rosembert 2024 Cited by 7 The aim of this study was to describe the opinions of patients undergoing treatment with originator biologics and medical consultants managing their conditions.
                            Learn more